Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Vir Biotechnology Inc. (VIR : NSD)

Sector: Healthcare

Close
(03-27-2026)
$8.40
Change
-$0.56 (-6.25%)
Volume 1,441,966
Open $8.91
Day Range $8.39 - $8.99
52 Week Low $4.16
52 Week High $10.94
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $1,171,945,135
Shares Outstanding 139,517,278
Book Value per Share $1.54
Earnings per Share -$3.16
Period
Loading......
Loading......

Legend

Vir Biotechnology Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
March 27, 2026 8.40
-$0.56 (-6.25%)
March 26, 2026 8.96
-$0.03 (-0.33%)
March 25, 2026 8.99
$0.42 (4.90%)
March 24, 2026 8.57
-$0.27 (-3.05%)
March 23, 2026 8.84
-$0.26 (-2.86%)
March 20, 2026 9.10
-$0.28 (-2.99%)
March 19, 2026 9.38
$0.06 (0.64%)
March 18, 2026 9.32
-$0.16 (-1.69%)
March 17, 2026 9.48
-$0.20 (-2.02%)
March 16, 2026 9.68
$0.42 (4.48%)
March 13, 2026 9.26
-$0.22 (-2.32%)
March 12, 2026 9.48
-$0.34 (-3.46%)
March 11, 2026 9.82
-$0.06 (-0.61%)
March 10, 2026 9.88
$0.08 (0.82%)
March 09, 2026 9.80
$0.25 (2.62%)
March 06, 2026 9.55
$0.45 (4.95%)
March 05, 2026 9.10
-$0.46 (-4.81%)
March 04, 2026 9.56
$0.65 (7.30%)
March 03, 2026 8.91
-$0.43 (-4.60%)
March 02, 2026 9.34
$0.25 (2.75%)
February 27, 2026 9.09
-$0.23 (-2.47%)
February 26, 2026 9.32
-$0.68 (-6.80%)
February 25, 2026 10.00
$0.51 (5.37%)
February 24, 2026 9.49
$2.06 (27.73%)
February 23, 2026 7.43
-$0.13 (-1.72%)
February 20, 2026 7.56
-$0.26 (-3.32%)
February 19, 2026 7.82
-$0.01 (-0.13%)
February 18, 2026 7.83
$0.33 (4.40%)
February 17, 2026 7.50
$0.03 (0.40%)
February 16, 2026 7.47
$0.00 (0.00%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports